DNAX — DNA Brands Income Statement
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
- $0.07m
- $1.00m
- $0.16m
Annual income statement for DNA Brands, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 October 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | 2013 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.006 | 1.17 | 1.19 | 0.249 | 0.157 |
Cost of Revenue | |||||
Gross Profit | — | 0.299 | 0.392 | 0.072 | -0.02 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.033 | 8.52 | 5.51 | 3.92 | 2.62 |
Operating Profit | -0.027 | -7.35 | -4.31 | -3.67 | -2.46 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.036 | -7.47 | -4.47 | -4.44 | -3.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.036 | -7.47 | -4.47 | -4.44 | -3.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.036 | -7.47 | -4.47 | -4.44 | -3.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.036 | -7.47 | -4.47 | -4.44 | -3.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1,158 | -192,694 | -81,005 | -61,011 | -25,658 |
Dividends per Share |